- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Fund Finance
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- Innovation Protection
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Corporate and Securities Litigation
- E-Discovery
- Global Construction and Infrastructure Disputes
- Innovation Protection
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy Transition
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- Artificial Intelligence (AI) and Machine Learning
- Buy American
- Crisis Management
- Doing Business in Latin America
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Events 168 results
Webinar
May 20, 2026
Clinical Trials Under the Microscope: Navigating FDA’s New Rules and DOJ Enforcement
Webinar
May 14, 2026
A Review of the FY 2027 IPPS and LTCH PPS Proposed Rule: Highlights and What to Expect
Webinar
May 12, 2026
Food & Beverage: Ultra-Processed Foods
Webinar
April 27, 2026
Securities Litigation and Life Sciences: A Review of the Risks Facing Manufacturers of FDA-Regulated Drugs and Medical Devices
Webinar
April 23, 2026
AI in EU Pharma: Navigating Efficiency, Innovation and Regulatory Challenges
Webinar
April 21, 2026
Challenging Payor Policies That Violate the CMS Two Midnight Rule
Webinar
March 25, 2026
Using Science Offensively in Litigation: Strategies From Recent Trials in Hellhole Jurisdictions
Webinar
March 12, 2026
Key Revisions of the EU General Pharmaceutical Legislation
Webinar
March 10, 2026
Can the EU Deliver On Its (Privacy) Simplification Agenda? A Practitioners' Views
Webinar
March 4, 2026
Understanding Supplemental Medicaid Opportunities via the Medicaid DSH Program
Webinar
February 26, 2026
2026 CA MCLE Institute
Webinar
February 25, 2026
Data Dividends vs. Red Lines: Navigating EU Data Laws and Cyber Threats in Pharma’s Data‑Driven Era